Edesa Biotech, Inc. Balance Sheet
EDSA|7 years of annual SEC 10-K data (FY2014-FY2021)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Edesa Biotech, Inc. had $15M in total assets and $7M in shareholders' equity as of FY2021.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.2M | $5.0M | $4.6M | $7.4M | $7.9M | $7.9M | $999.0K |
| Inventory | - | - | $224.3K | $68.1K | $249.4K | $557.3K | - |
| Current Assets | $12.1M | $8.1M | $10.7M | $6.8M | $12.1M | $14.1M | $14.1M |
| PP&E (Net) | $15.0K | $14.8K | $1.1M | $879.5K | $756.1K | $387.4K | $387.4K |
| Total Assets | $14.6M | $10.8M | $11.8M | $7.7M | $12.9M | $14.5M | $8.5M |
| Current Liabilities | $1.5M | $1.5M | $493.4K | $320.9K | $623.6K | $1.4M | $1.4M |
| Shareholders' Equity | $6.6M | $5.3M | $7.4M | $12.3M | -$2.2M | -$2.2M | $902.2K |